Desyncra™ is a medical technology company for the treatment of brain-related conditions. Our award-winning Coordinated Reset (CR®) Neuromodulation technology was developed by Professor Peter Tass at the Jülich Research Centre, and can be used for the treatment of: tinnitus, Parkinson's disease, epilepsy, and migraine. Our T30 device for tinnitus has FDA approval and the CE mark and is currently available in the UK, Germany, Netherlands and Switzerland.